Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS
· Delayed Price · Currency is USD
26.59
-0.47 (-1.74%)
At close: Dec 5, 2025
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 333.18B JPY in the quarter ending September 30, 2025, with 5.54% growth. This brings the company's revenue in the last twelve months to 1.21T, up 6.25% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.
Revenue (ttm)
1,213.71B JPY
Revenue Growth
+6.25%
P/S Ratio
10.63
Revenue / Employee
241.49M JPY
Employees
5,026
Market Cap
87.18B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,170.61B | 59.24B | 5.33% |
| Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
| Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
Chugai Pharmaceutical News
- 11 days ago - Chugai Pharmaceutical Teams With Biomy For Development Of AI-based Cancer Pathology Program - Nasdaq
- 6 weeks ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq
- 6 weeks ago - Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
- 7 weeks ago - Rani Therapeutics surges on Chugai licensing deal, private placement - Seeking Alpha
- 7 weeks ago - Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases - Benzinga
- 4 months ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha